Global GABA (CAS 512) Market is expected to grow at a CAGR of XX% during the forecast period. The market is driven by the increasing demand for GABA in pharmaceuticals, food and beverage, and animal feeds. The growth of this market is also attributed to the increasing awareness about its health benefits among consumers. The global GABA (CAS 512) market has been segmented on the basis of type, application, and region. On the basis of type, it has been classified into chemical synthesis and biological fermentation. On the basis of application, it has been classified into pharmaceuticals, food & beverage industry and animal feed industry. On the basis of region it has been classified into North America, Latin America Europe Asia Pacific Middle East & Africa (MEA). GABA is a neurotransmitter that is found in the brain and spinal cord. It is an inhibitory neurotransmitter, which means it slows down nerve impulses. GABA has been shown to be effective in treating anxiety, depression, insomnia, and seizures.
Industry Growth Insights published a new data on “GABA (CAS 56-12-2) Market”. The research report is titled “GABA (CAS 56-12-2) Market research by Types (Chemical Synthesis, Biological Fermentation), By Applications (Pharmaceuticals, Food & Beverage, Animal Feeds, Others), By Players/Companies Pharma Foods International, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
GABA (CAS 56-12-2) Market Research Report
By Type
Chemical Synthesis, Biological Fermentation
By Application
Pharmaceuticals, Food & Beverage, Animal Feeds, Others
By Companies
Pharma Foods International, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global GABA (CAS 56-12-2) Market Report Segments:
The global GABA (CAS 56-12-2) market is segmented on the basis of:
Types
Chemical Synthesis, Biological Fermentation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceuticals, Food & Beverage, Animal Feeds, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pharma Foods International
- Sekisui Chemical
- Zhejiang YiWan Biolabs
- Shanghai Richen
- Guangdong Luckerkong Biotech
- Tianjin Shijitianlong Biotech
- Ningxiang Jiayuan Biology Technology
- Zhejiang Tianrui Chemical
- Taizhou Xinyou Pharmaceutical & Chemical
Highlights of The GABA (CAS 56-12-2) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemical Synthesis
- Biological Fermentation
- By Application:
- Pharmaceuticals
- Food & Beverage
- Animal Feeds
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GABA (CAS 56-12-2) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GABA is a neurotransmitter that helps to regulate nerve cells in the brain. It is also involved in controlling muscle activity and blood pressure.
Some of the key players operating in the gaba (cas 56-12-2) market are Pharma Foods International, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong Biotech, Tianjin Shijitianlong Biotech, Ningxiang Jiayuan Biology Technology, Zhejiang Tianrui Chemical, Taizhou Xinyou Pharmaceutical & Chemical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. GABA (CAS 56-12-2) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. GABA (CAS 56-12-2) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. GABA (CAS 56-12-2) Market - Supply Chain
4.5. Global GABA (CAS 56-12-2) Market Forecast
4.5.1. GABA (CAS 56-12-2) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. GABA (CAS 56-12-2) Market Size (000 Units) and Y-o-Y Growth
4.5.3. GABA (CAS 56-12-2) Market Absolute $ Opportunity
5. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
5.3.1. Chemical Synthesis
5.3.2. Biological Fermentation
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
6.3.1. Pharmaceuticals
6.3.2. Food & Beverage
6.3.3. Animal Feeds
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global GABA (CAS 56-12-2) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. GABA (CAS 56-12-2) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global GABA (CAS 56-12-2) Demand Share Forecast, 2019-2026
9. North America GABA (CAS 56-12-2) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
9.4.1. Pharmaceuticals
9.4.2. Food & Beverage
9.4.3. Animal Feeds
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
9.7.1. Chemical Synthesis
9.7.2. Biological Fermentation
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America GABA (CAS 56-12-2) Demand Share Forecast, 2019-2026
10. Latin America GABA (CAS 56-12-2) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
10.4.1. Pharmaceuticals
10.4.2. Food & Beverage
10.4.3. Animal Feeds
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
10.7.1. Chemical Synthesis
10.7.2. Biological Fermentation
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America GABA (CAS 56-12-2) Demand Share Forecast, 2019-2026
11. Europe GABA (CAS 56-12-2) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
11.4.1. Pharmaceuticals
11.4.2. Food & Beverage
11.4.3. Animal Feeds
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
11.7.1. Chemical Synthesis
11.7.2. Biological Fermentation
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Aalysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe GABA (CAS 56-12-2) Demand Share, 2019-2026
12. Asia Pacific GABA (CAS 56-12-2) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
12.4.1. Pharmaceuticals
12.4.2. Food & Beverage
12.4.3. Animal Feeds
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
12.7.1. Chemical Synthesis
12.7.2. Biological Fermentation
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific GABA (CAS 56-12-2) Demand Share, 2019-2026
13. Middle East & Africa GABA (CAS 56-12-2) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa GABA (CAS 56-12-2) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa GABA (CAS 56-12-2) Market Size and Volume Forecast by Application
13.4.1. Pharmaceuticals
13.4.2. Food & Beverage
13.4.3. Animal Feeds
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa GABA (CAS 56-12-2) Market Size and Volume Forecast by Type
13.7.1. Chemical Synthesis
13.7.2. Biological Fermentation
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa GABA (CAS 56-12-2) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global GABA (CAS 56-12-2) Market: Market Share Analysis
14.2. GABA (CAS 56-12-2) Distributors and Customers
14.3. GABA (CAS 56-12-2) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pharma Foods International
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sekisui Chemical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Zhejiang YiWan Biolabs
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shanghai Richen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Guangdong Luckerkong Biotech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Tianjin Shijitianlong Biotech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ningxiang Jiayuan Biology Technology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zhejiang Tianrui Chemical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Taizhou Xinyou Pharmaceutical & Chemical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook